pilsicainide has been researched along with Extrasystole, Ventricular in 6 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
| Excerpt | Relevance | Reference |
|---|---|---|
| " During hospitalization, atrial fibrillation developed, and oral pilsicainide was administered." | 3.71 | Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. ( Aizawa, Y; Chinushi, M; Chinushi, Y; Toida, T, 2002) |
| "Frequent premature ventricular complexes (PVCs) with two different left bundle branch block patterns developed during ST segment elevation." | 1.35 | Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Tagawa, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamasaki, H | 1 |
| Tada, H | 1 |
| Sekiguchi, Y | 1 |
| Aonuma, K | 1 |
| Maruyama, T | 1 |
| Karshima, E | 1 |
| Hiramatsu, S | 1 |
| Odashiro, K | 1 |
| Chinushi, M | 3 |
| Tagawa, M | 1 |
| Izumi, D | 2 |
| Furushima, H | 2 |
| Aizawa, Y | 3 |
| Mizobuchi, M | 1 |
| Enjoji, Y | 1 |
| Nakamura, S | 1 |
| Muranishi, H | 1 |
| Utsunomiya, M | 1 |
| Funatsu, A | 1 |
| Kobayashi, T | 1 |
| Watanabe, H | 1 |
| Chinushi, Y | 1 |
| Toida, T | 1 |
6 other studies available for pilsicainide and Extrasystole, Ventricular
| Article | Year |
|---|---|
Right coronary cusp as a new window of ablation for pilsicainide-induced ventricular premature contractions in a patient with Brugada syndrome.
Topics: Adult; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Ventricl | 2016 |
Menstruation-dependent idiopathic ventricular arrhythmia.
Topics: Adult; Anti-Asthmatic Agents; Electrocardiography, Ambulatory; Female; Humans; Lidocaine; Menstruati | 2008 |
Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Injections | 2009 |
Ventricular late potential in patients with apparently normal electrocardiogram; predictor of Brugada syndrome.
Topics: Adult; Aged; Aged, 80 and over; Brugada Syndrome; Chi-Square Distribution; Electrocardiography; Fema | 2010 |
Multiple premature beats triggered ventricular arrhythmias during pilsicainide infusion in a patient with inferior ST-segment elevation.
Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Humans; Infusions, Intraven | 2006 |
Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina.
Topics: Acetylcholine; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 2002 |